Plymouth, MN, United States of America

Arslan Mazhar Malik

This inventor holds 1 USPTO granted patent. Top assignee: Reprieve Cardiovascular, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arslan Mazhar Malik. Retrieved from https://idiyas.com/inventor/arslan-mazhar-malik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arslan Mazhar Malik and Fluid Therapy Innovation.

Introduction

Arslan Mazhar Malik is an inventor associated with Plymouth, Minnesota, and Reprieve Cardiovascular, Inc. His work includes a patented approach to managing urine output and fluid therapy.

Latest Patents

Malik is associated with 1 patent, titled “Fluid Therapy Based on Estimated Excess Fluid, and Associated Systems and Methods.” The technology describes devices, systems, and methods for managing a patient’s urine output. An exemplary method uses an estimate of excess fluid, the patient’s urine output rate, and the diuretic dosage rate, along with information about net fluid loss or the estimated fluid remaining. Based on these inputs, the system can provide guidance for adjusting fluid therapy, such as administering an additional diuretic or increasing hydration-fluid infusion.

Career Highlights

The patent reflects Malik’s contribution to technology for supporting fluid-management decisions. His work is associated with Reprieve Cardiovascular, Inc.

Collaborations

Malik’s listed coworker is Jeffrey Testani. The patent’s described approach brings together patient measurements and treatment inputs to inform fluid-therapy adjustments.

Conclusion

Arslan Mazhar Malik’s patent addresses a practical challenge in patient care by outlining a data-informed method for managing urine output and adjusting fluid therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…